Kazia Therapeutics Limited KZIA

$ 6.59 19.38%

Annual report 2022
added 10-17-2022

Kazia Therapeutics Limited Balance Sheet 2011-2024 | KZIA

Annual Balance Sheet Kazia Therapeutics Limited

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-5.43 M	-5.87 M	-14.4 M	-33.4 M	-44.4 M	205 K	-1.32 M	-	-
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	11.6 M	11.9 M	3.87 M	5.08 M	5.05 M	5.19 M	154 K	-	-	-	7 K	104 K
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	16.3 M	20.2 M	8.94 M	6.98 M	8.93 M	10.6 M	1.59 M	1.78 M	3.25 M	1.71 M	3.87 M	8.31 M
Deferred Revenue	-	-	-	-	138 K	41 K	-	-	-	-	1.08 M	2.14 M
Retained Earnings	-68.3 M	-44.2 M	-36.2 M	-24.9 M	-14.6 M	-171 M	-161 M	-148 M	-141 M	-134 M	-192 M	-187 M
Total Assets	35 M	58.1 M	23.1 M	21.2 M	28.2 M	35.9 M	35.5 M	46.1 M	4.66 M	5.75 M	8.98 M	12.7 M
Cash and Cash Equivalents	7.36 M	27.6 M	8.76 M	5.43 M	5.96 M	14.5 M	33.5 M	-	-	-	-	-
Book Value	18.6 M	37.9 M	14.1 M	14.2 M	19.2 M	25.3 M	33.9 M	44.4 M	1.41 M	4.04 M	5.11 M	4.42 M
Total Shareholders Equity	18.6 M	37.9 M	14.1 M	14.2 M	19.2 M	25.3 M	33.4 M	-	-	-	-	-

All numbers in AUD currency

Quarterly Balance Sheet Kazia Therapeutics Limited

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	11.9 M	-	-	-	3.87 M	-	-	-	5.08 M	-	-	-	5.05 M	-	-	-	5.19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	20.2 M	-	-	-	8.94 M	-	-	-	6.98 M	-	-	-	8.93 M	-	-	-	10.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-	-	-44.2 M	-	-	-	-36.2 M	-	-	-	-24.9 M	-	-	-	-14.6 M	-	-	-	-171 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	-	-	58.1 M	-	-	-	23.1 M	-	-	-	21.2 M	-	-	-	28.2 M	-	-	-	35.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	-	-	27.6 M	-	-	-	8.76 M	-	-	-	5.43 M	-	-	-	5.96 M	-	-	-	14.5 M	-	-	-	33.5 M	-	-	-	44.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	-	-	37.9 M	-	-	-	14.1 M	-	-	-	14.2 M	-	-	-	19.2 M	-	-	-	25.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	-	-	37.9 M	-	-	-	14.1 M	-	-	-	14.2 M	-	-	-	19.2 M	-	-	-	25.3 M	-	-	-	33.9 M	-	-	-	44.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in AUD currency